Centogene N.V. - stock earnings
CNTG Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -13.3 million USD | 13.4 million USD |
| 2023Q1 | -8.5 million USD | 14.2 million USD |
| 2022Q3 | -7.7 million USD | 12.8 million USD |
| 2022Q2 | -12.4 million USD | 11.7 million USD |
| 2022Q1 | -7.2 million USD | 11.5 million USD |
| 2021Q4 | -14.0 million USD | 48.8 million USD |
| 2021Q3 | -25.1 million USD | 35.0 million USD |
| 2021Q2 | -9.5 million USD | 61.5 million USD |
| 2021Q1 | 3.9 million USD | 82.4 million USD |
| 2020Q4 | 4.1 million USD | 85.6 million USD |
| 2020Q3 | -6.6 million USD | 42.6 million USD |
| 2020Q2 | -11.6 million USD | 10.9 million USD |
| 2020Q1 | -5.5 million USD | 16.8 million USD |
| 2019Q4 | -5.6 million USD | 17.1 million USD |
| 2019Q3 | -4.7 million USD | 12.7 million USD |
| 2019Q2 | -7.1 million USD | 12.7 million USD |
| 2019Q1 | -5.9 million USD | 12.0 million USD |
| 2018Q4 | -4.0 million USD | 11.5 million USD |
| 2018Q3 | -1.4 million USD | 15.6 million USD |
| 2018Q2 | -3.8 million USD | 9.8 million USD |
| 2018Q1 | -4.1 million USD | 10.5 million USD |
| 2017Q4 | -1.2 million USD | 10.5 million USD |
CNTG Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -41.5 million USD | 50.9 million USD |
| 2021 | -53.3 million USD | 216.0 million USD |
| 2020 | -26.0 million USD | 156.4 million USD |
| 2019 | -23.4 million USD | 54.6 million USD |
| 2018 | -13.0 million USD | 46.3 million USD |
| 2017 | -6.5 million USD | 37.8 million USD |
| 2016 | -5.6 million USD | 29.1 million USD |
CNTG
Price: $0.44
52 week price:
Earnings Per Share: -1.56 USD
P/E Ratio: -0.59
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 6500
Market Capitalization: 11.7 million